NCT Number: NCT03251105
Supreme Versus Proseal Laryngeal Mask Airways in Infants
In this study, the Supreme and ProSeal LMAs in infants were compared by measuring their performance characteristics, including insertion features, ventilation parameters, induced changes in hemodynamics and rates of postoperative complications.
Looking for future studies?
Notify MeKey information
Conditions
Age range
Up to 12 month
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
About this study
Both the Supreme™ and ProSeal™ laryngeal mask airways (LMAs) are widely used for paediatric anaesthesia; however, LMA use in infants is limited, as many anaesthesiologists prefer to use tracheal intubation in infants.
In this study, the Supreme and ProSeal LMAs in infants were compared by measuring their performance characteristics, including insertion features, ventilation parameters, induced changes in hemodynamics and rates of postoperative complications.
Infants of ASA physical status I who were scheduled for elective, minor, lower abdominal surgery were divided into two groups: the Supreme LMA group and the ProSeal LMA group. Heart rate (HR), oxygen saturation and end tidal carbon dioxide values were recorded both before and after LMA insertion, as well as both before and after extubation. After extubation, complications and adverse effects were noted.
Demographics and surgical data were similar between the two groups. LMA insertion times for the ProSeal group were shorter, the leakage pressure for the ProSeal group was statistically higher. The ProSeal LMA is superior to the Supreme LMA for use in infants, due to its ease of insertion, high oropharyngeal leakage pressure and fewer induced changes in hemodynamics.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- scheduled for elective, minor (<1 hour duration), lower abdominal surgery, including unilateral herniorrhaphy and unilateral orchidopexy
Exclusion criteria
- premature birth, potentially difficult airway, clinically significant upper respiratory tract infection and risk of aspiration, such as gastro-oesophageal reflux disease
Treatment and study plan
Primary outcomes
-
performance characteristics
Time frame: operation duration
insertion time in minutes
Secondary outcomes
-
haemodynamics
Time frame: operation duration
end tidal CO2 (EtCO2) in mmHg
Sponsors and collaborators
Lead sponsor
Sisli Hamidiye Etfal Training and Research Hospital
Other
Registry information
Official study title
Comparison of the Supreme™ And Proseal™ Laryngeal Mask Airways in Infants: A Prospective Randomised Clinical Study
Important dates
- Study start
- 2016
- Primary completion
- 2016
- Study completion
- 2017
- First posted
- Aug 16, 2017
- Registry last updated
- Aug 16, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The Effects of Individualized Lung-protective Ventilation With Lung Dynamic Compliance-guided Positive End-expiratory Pressure(PEEP) Titration on Postoperative Pulmonary Complications of Pediatric Video-assisted Thoracoscopic Surgery
NCT05386901
Anesthesia, Surgery
Shenzhen, Guangdong, China
View Trial DetailsRisk Factors for Chronic Postoperative Pain After Elective Nephrectomy
NCT06673979
Acute Pain, Acute Pain, Postoperative
Istanbul, Turkey (Türkiye)
View Trial DetailsDetection of Cerebral Ischemia With Artificial Intelligence.
NCT03919370
Anesthesia, Arterial Occlusive Diseases
Gothenburg, Sweden
View Trial DetailsPersonalized Hemodynamic Management in High-risk Major Abdominal Surgery
NCT05648279
Anesthesia, Cardiac Output
Graz, Austria
View Trial Details